2/22/2013

An Emergo Group survey of 650 senior medtech executives found that 11% would shrink their workforce to help manage the costs of the 2.3% medical device tax, while about 12% would cut their research and development funding. Meanwhile, more than 40% of respondents said they would deal with the tax by raising product prices.

Related Summaries